JISCMail - EVIDENCE-BASED-HEALTH Archives

Email discussion lists for the UK Education and Research communities

Subscriber's Corner

Email Lists

EVIDENCE-BASED-HEALTH Archives

February 2023

View:

Show Author | Hide Author

		LISTSERV Archives
		EVIDENCE-BASED-HEALTH Home

Options

Subscribe or Unsubscribe

Get Password

Subject	From	Date	Size
Last chance to register for Steve Raudenbush seminar: HLMs and Causal Inference	Michael Zyphur	Tue, 28 Feb 2023 14:45:20 +1100	215 lines
Last chance for Multilevel SEM in Mplus: Location-Scale Models - livestream seminar	Michael Zyphur	Thu, 23 Feb 2023 20:52:11 +1100	210 lines
Last chance for Advanced Panel Data Modeling - livestream seminar	Michael Zyphur	Wed, 22 Feb 2023 20:14:36 +1100	194 lines
Re: Health Alert on mRNA COVID-19 Vaccine Safety	Wouter Havinga	Mon, 20 Feb 2023 14:27:18 +0000	1020 lines
Re: Health Alert on mRNA COVID-19 Vaccine Safety	Benjamin Djulbegovic MD	Mon, 20 Feb 2023 13:20:29 +0000	812 lines
Re: Health Alert on mRNA COVID-19 Vaccine Safety	David Nunan	Mon, 20 Feb 2023 13:03:24 +0000	718 lines
Re: Health Alert on mRNA COVID-19 Vaccine Safety	Benjamin Djulbegovic MD	Mon, 20 Feb 2023 12:53:21 +0000	658 lines
ONLINE COURSE: Practical Statistics for Medical Research (UCL), 13-16 June 2023	Omar, Rumana	Mon, 20 Feb 2023 12:07:16 +0000	185 lines
Re: Health Alert on mRNA COVID-19 Vaccine Safety	David Nunan	Mon, 20 Feb 2023 10:24:03 +0000	577 lines
Re: Health Alert on mRNA COVID-19 Vaccine Safety	Dr Amy Price	Sat, 18 Feb 2023 23:21:38 -0500	428 lines
Last chance to Register for Time-Series Methods: Dynamic Modeling - livestream seminar	Michael Zyphur	Sun, 19 Feb 2023 12:26:45 +1100	129 lines
Re: Health Alert on mRNA COVID-19 Vaccine Safety	Bill Cayley, Jr	Sun, 19 Feb 2023 01:20:05 +0000	436 lines
Re: Health Alert on mRNA COVID-19 Vaccine Safety	Benjamin Djulbegovic MD	Sat, 18 Feb 2023 23:22:01 +0000	356 lines
Re: Health Alert on mRNA COVID-19 Vaccine Safety	Birnbaum, David	Sat, 18 Feb 2023 18:45:35 +0000	160 lines
Re: Health Alert on mRNA COVID-19 Vaccine Safety	Stanley, Donald E	Sat, 18 Feb 2023 18:21:06 +0000	284 lines
Fwd: Health Alert on mRNA COVID-19 Vaccine Safety	Amy Price	Sat, 18 Feb 2023 18:18:50 +0000	851 lines
Job opportunity with EBI Centre - ITALY	Centro di Ricerca e Servizio di Epidemiologia, Biostatistica e Informatica Medica	Fri, 17 Feb 2023 12:05:40 +0000	200 lines
Re: Quality assessment or risk of bias for qualitative synthesis?	Hannah Greenwood	Fri, 17 Feb 2023 04:57:28 +0000	137 lines
Re: Quality assessment or risk of bias for qualitative synthesis?	Dr Amy Price	Thu, 16 Feb 2023 23:41:29 -0500	208 lines
Re: Quality assessment or risk of bias for qualitative synthesis?	David Richard Leslie Cawthorpe	Fri, 17 Feb 2023 02:47:50 +0000	115 lines
Re: Quality assessment or risk of bias for qualitative synthesis?	Hannah Greenwood	Fri, 17 Feb 2023 01:51:27 +0000	86 lines
Re: Quality assessment or risk of bias for qualitative synthesis?	Dr Amy Price	Thu, 16 Feb 2023 20:36:29 -0500	79 lines
Quality assessment or risk of bias for qualitative synthesis?	Hannah Greenwood	Fri, 17 Feb 2023 00:52:49 +0000	38 lines
LAST CHANCE TO BOOK: Uni. of Glasgow Course: Survival Analysis for HTA	Miriam Yentumi	Thu, 16 Feb 2023 15:04:28 +0000	349 lines
Cochrane Evidence Synthesis and Methods: A new Cochrane Journal - 9 March 2023 webinar	Carol Lefebvre	Wed, 15 Feb 2023 18:04:43 +0000	208 lines
Last chance to Register for Panel Data Modeling and Methods - livestream seminar	Michael Zyphur	Tue, 14 Feb 2023 23:32:00 +1100	390 lines
SV: Cochrane Review on Physical interventions to reduce respiratory viruses	Atle Fretheim	Tue, 14 Feb 2023 11:28:32 +0000	1320 lines
Re: tool to evaluate systematic reviews of diagnostic test studies = link to Cochrane DTA Handbook	Carol Lefebvre	Tue, 14 Feb 2023 10:09:09 +0000	377 lines
Re: tool to evaluate systematic reviews of diagnostic test studies	Clare Davenport	Tue, 14 Feb 2023 09:19:38 +0000	231 lines
Re: New forms of RCT testing	Atle Fretheim	Mon, 13 Feb 2023 18:00:18 +0000	683 lines
Re: tool to evaluate systematic reviews of diagnostic test studies	Andreas Lundh	Mon, 13 Feb 2023 18:35:13 +0100	155 lines
Re: New forms of RCT testing	Susan Bewley	Mon, 13 Feb 2023 17:32:37 +0000	644 lines
Re: (External Email) SV: New forms of RCT testing	Benson, Teresa	Mon, 13 Feb 2023 16:31:05 +0000	735 lines
SV: New forms of RCT testing	Atle Fretheim	Mon, 13 Feb 2023 15:59:05 +0000	542 lines
Re: Cochrane Review on Physical interventions to reduce respiratory viruses	Benjamin Djulbegovic MD	Mon, 13 Feb 2023 15:58:05 +0000	924 lines
Re: Cochrane Review on Physical interventions to reduce respiratory viruses	Bill Cayley, Jr	Mon, 13 Feb 2023 15:56:36 +0000	1335 lines
Re: New forms of RCT testing	Susan Bewley	Mon, 13 Feb 2023 15:44:35 +0000	312 lines
Re: tool to evaluate systematic reviews of diagnostic test studies	David Nunan	Mon, 13 Feb 2023 15:43:31 +0000	102 lines
tool to evaluate systematic reviews of diagnostic test studies	Shaneyfelt, Terry	Mon, 13 Feb 2023 15:33:00 +0000	107 lines
Re: Cochrane Review on Physical interventions to reduce respiratory viruses	Jon Brassey	Mon, 13 Feb 2023 14:52:18 +0000	1054 lines
Re: The problem and futility of measuring lipids in individual people	Luiza de Oliveira Rodrigues	Mon, 13 Feb 2023 11:19:14 -0300	2252 lines
Re: Cochrane Review on Physical interventions to reduce respiratory viruses	David Nunan	Mon, 13 Feb 2023 14:12:30 +0000	805 lines
Re: Cochrane Review on Physical interventions to reduce respiratory viruses	McCormack, James	Mon, 13 Feb 2023 14:03:50 +0000	1031 lines
Re: Cochrane Review on Physical interventions to reduce respiratory viruses	Xilia Faye	Mon, 13 Feb 2023 08:31:45 -0500	491 lines
Re: Cochrane Review on Physical interventions to reduce respiratory viruses	Dr Amy Price	Mon, 13 Feb 2023 01:02:02 -0500	491 lines
Re: Cochrane Review on Physical interventions to reduce respiratory viruses	Benjamin Djulbegovic MD	Mon, 13 Feb 2023 01:44:04 +0000	526 lines
Re: RES: Cochrane Review on Physical interventions to reduce respiratory viruses	Bill Cayley, Jr	Sun, 12 Feb 2023 23:21:54 +0000	362 lines
Re: The problem and futility of measuring lipids in individual people	McCormack, James	Sat, 11 Feb 2023 22:27:04 +0000	1871 lines
Re: The problem and futility of measuring lipids in individual people	Benjamin Djulbegovic MD	Sat, 11 Feb 2023 22:11:35 +0000	1968 lines
Re: The problem and futility of measuring lipids in individual people	Huw Llewelyn [hul2]	Sat, 11 Feb 2023 22:02:32 +0000	1812 lines
Re: The problem and futility of measuring lipids in individual people	Huw Llewelyn [hul2]	Sat, 11 Feb 2023 21:42:21 +0000	1498 lines
Re: The problem and futility of measuring lipids in individual people	McCormack, James	Sat, 11 Feb 2023 20:23:10 +0000	1521 lines
Re: The problem and futility of measuring lipids in individual people	McCormack, James	Sat, 11 Feb 2023 20:14:11 +0000	694 lines
Re: The problem and futility of measuring lipids in individual people	Benjamin Djulbegovic MD	Sat, 11 Feb 2023 20:13:38 +0000	1235 lines
Re: The problem and futility of measuring lipids in individual people	Huw Llewelyn [hul2]	Sat, 11 Feb 2023 20:04:42 +0000	1144 lines
Re: The problem and futility of measuring lipids in individual people	Benjamin Djulbegovic MD	Sat, 11 Feb 2023 19:02:04 +0000	888 lines
The problem and futility of measuring lipids in individual people	Huw Llewelyn [hul2]	Sat, 11 Feb 2023 16:58:31 +0000	683 lines
Re: The problem and futility of measuring lipids in individual people	Huw Llewelyn [hul2]	Sat, 11 Feb 2023 15:02:54 +0000	685 lines
Re: The problem and futility of measuring lipids in individual people	Joshua Davis	Sat, 11 Feb 2023 08:53:33 -0600	739 lines
Re: The problem and futility of measuring lipids in individual people	Huw Llewelyn [hul2]	Sat, 11 Feb 2023 14:33:46 +0000	569 lines
Re: The problem and futility of measuring lipids in individual people	McCormack, James	Sat, 11 Feb 2023 04:31:42 +0000	319 lines
Re: The problem and futility of measuring lipids in individual people	christoph schnelle	Fri, 10 Feb 2023 20:26:14 +0000	349 lines
RES: Cochrane Review on Physical interventions to reduce respiratory viruses	Caue Freitas Monaco	Fri, 10 Feb 2023 16:31:55 -0300	81 lines
Re: (External Email) Cochrane Review on Physical interventions to reduce respiratory viruses	Benson, Teresa	Fri, 10 Feb 2023 17:44:16 +0000	93 lines
Cochrane Review on Physical interventions to reduce respiratory viruses	Anoop Balachandran	Fri, 10 Feb 2023 17:14:37 +0000	42 lines
Re: The problem and futility of measuring lipid's in individual people	K Hopayian	Fri, 10 Feb 2023 18:30:05 +0200	140 lines
Re: The problem and futility of measuring lipids in individual people	Huw Llewelyn [hul2]	Fri, 10 Feb 2023 10:05:45 +0000	261 lines
Re: The problem and futility of measuring lipids in individual people	Huw Llewelyn [hul2]	Fri, 10 Feb 2023 09:42:34 +0000	248 lines
Re: The problem and futility of measuring lipids in individual people	Rakesh Biswas	Fri, 10 Feb 2023 09:52:52 +0530	146 lines
The problem and futility of measuring lipids in individual people	McCormack, James	Thu, 9 Feb 2023 17:25:29 +0000	86 lines
The problem and futility of measuring lipid's in individual people	McCormack, James	Thu, 9 Feb 2023 17:04:38 +0000	72 lines
Re: Ideas for group work exploring uncertainty	David Richard Leslie Cawthorpe	Thu, 9 Feb 2023 11:43:53 +0000	136 lines
Re: Ideas for group work exploring uncertainty	Rakesh Biswas	Thu, 9 Feb 2023 16:42:50 +0530	105 lines
Ideas for group work exploring uncertainty	Jon Brassey	Thu, 9 Feb 2023 11:02:47 +0000	61 lines
Re: SSRIs and TCADs co-prescribing	Rakesh Biswas	Tue, 7 Feb 2023 10:52:23 +0530	367 lines
Free most read article collection from Bristol University Press and Policy Press	Sian Carrington	Mon, 6 Feb 2023 17:24:25 +0000	273 lines
Re: SSRIs and TCADs co-prescribing	K Hopayian	Mon, 6 Feb 2023 16:54:20 +0000	393 lines
Re: SSRIs and TCADs co-prescribing	David Richard Leslie Cawthorpe	Mon, 6 Feb 2023 04:34:06 +0000	281 lines
Re: SSRIs and TCADs co-prescribing	Rakesh Biswas	Mon, 6 Feb 2023 09:58:05 +0530	295 lines
Re: SSRIs and TCADs co-prescribing	K Hopayian	Sun, 5 Feb 2023 13:30:42 +0000	297 lines
Re: SSRIs and TCADs co-prescribing	K Hopayian	Sun, 5 Feb 2023 13:28:57 +0000	722 lines
Re: SSRIs and TCADs co-prescribing	K Hopayian	Sun, 5 Feb 2023 13:28:23 +0000	604 lines
Re: SSRIs and TCADs co-prescribing	Susan Bewley	Sun, 5 Feb 2023 13:13:57 +0000	1322 lines
Re: SSRIs and TCADs co-prescribing	Benjamin Djulbegovic MD	Sun, 5 Feb 2023 13:10:27 +0000	1123 lines
Re: SSRIs and TCADs co-prescribing	Benjamin Djulbegovic MD	Sun, 5 Feb 2023 12:31:51 +0000	661 lines
Re: SSRIs and TCADs co-prescribing	Michael Bennett	Sun, 5 Feb 2023 06:05:51 +0000	1040 lines
Re: SSRIs and TCADs co-prescribing	McCormack, James	Sun, 5 Feb 2023 05:15:54 +0000	472 lines
Re: SSRIs and TCADs co-prescribing	David Richard Leslie Cawthorpe	Sun, 5 Feb 2023 04:58:59 +0000	584 lines
Re: SSRIs and TCADs co-prescribing	Caroline Blaine	Sun, 5 Feb 2023 04:33:59 +0000	619 lines
Re: SSRIs and TCADs co-prescribing	Benjamin Djulbegovic MD	Sun, 5 Feb 2023 04:06:36 +0000	456 lines
Re: SSRIs and TCADs co-prescribing	Joshua Davis	Sat, 4 Feb 2023 20:44:43 -0600	243 lines
Re: Is EBM non-existent in New Zealand or suppressed?	Wouter Havinga	Thu, 2 Feb 2023 08:30:26 +0000	2702 lines
STEM researchers with disabilities in Brazil, South Africa and Indonesia - focus group/interview request	Cathy Mungall-Baldwin	Wed, 1 Feb 2023 20:52:45 +0000	230 lines